ConductScience.org, home

Comparison · NCT03348683-85d1a504

Propranolol vs Placebo: Number of Neonates With Hypoglycemia

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Propranolol vs Placebo: Number of Neonates With Hypoglycemia. Trial comparisons, record NCT03348683-85d1a504. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03348683-85d1a504

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.2440.1420.387wilson
Risk in group 20.1630.08510.29wilson
Risk difference, group 1 minus group 20.0812-0.08180.244newcombe hybrid score
Risk ratio, group 1 over group 21.50.6623.39log
Odds ratio, group 1 over group 21.660.5994.59log
Number needed to treat, for one more participant with the outcome on Propranolol than on Placebo12.3from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1PropranololAfter induction was started with Foley or misoprostol placement, 30 minutes passed before administration of propranolol 2mg of IV push1145OG000
Group 2PlaceboAfter induction was started with Foley or misoprostol placement, 30 minutes passed before administration of an equivalent quantity in milliliters of IV normal saline849OG001

Outcome

Type
SECONDARY
Title
Number of Neonates With Hypoglycemia
Description
Neonatal outcome - Number of neonates with hypoglycemia (blood glucose \<50).~This population includes only the neonates who had heelsticks to check their blood glucose, which is not a universal practice and was not required by the protocol or IRB. The neonates included were those who met the nursery's risk-based protocol to check blood glucose after birth (ex: infants of diabetic mothers, fetal growth restriction, macrosomia, or symptoms suggestive of hypoglycemia)
Time frame
Day 1
Population
This population includes the neonates who had heelsticks to check their blood glucose.

Source ClinicalTrials.gov

Trial

Title
Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients
NCT number
NCT03348683
Phases
PHASE2
Conditions
Induction of Labor Affected Fetus / Newborn
Interventions
Propranolol, Placebo
Lead sponsor
Icahn School of Medicine at Mount Sinai
Results first posted
2019-12-26

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03348683-85d1a504